Metsera becomes the most sought-after biotech in 2025 The global pharmaceutical industry is witnessing one of its fiercest acquisition battles in years as Pfizer raises its...
The bidding war between Pfizer and Novo Nordisk for obesity drug developer Metsera has escalated sharply this week, as both pharmaceutical giants revised their offers in...
